UMediC Group Berhad (0256) - Total Liabilities
Based on the latest financial reports, UMediC Group Berhad (0256) has total liabilities worth RM11.72 Million MYR (≈ $2.94 Million USD) as of October 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 0256 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
UMediC Group Berhad - Total Liabilities Trend (2020–2025)
This chart illustrates how UMediC Group Berhad's total liabilities have evolved over time, based on quarterly financial data. See 0256 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
UMediC Group Berhad Competitors by Total Liabilities
The table below lists competitors of UMediC Group Berhad ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Denge Yatirim Holding AS
IS:DENGE
|
Turkey | TL576.37 Million |
|
SG Corporation
KO:004060
|
Korea | ₩29.04 Billion |
|
Mereo BioPharma Group plc
F:MAH0
|
Germany | €5.00 Million |
|
Stakeholder Gold Corp
V:SRC
|
Canada | CA$384.54K |
|
Levinski Ofer
TA:LEOF
|
Israel | ILA218.09 Million |
|
TDb Split Corp
TO:XTD
|
Canada | CA$47.56 Million |
|
Midland Exploration Inc
V:MD
|
Canada | CA$2.11 Million |
|
Elcomtec Co. Ltd
KQ:037950
|
Korea | ₩12.73 Billion |
Liability Composition Analysis (2020–2025)
This chart breaks down UMediC Group Berhad's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 0256 stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 7.22 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how UMediC Group Berhad's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for UMediC Group Berhad (2020–2025)
The table below shows the annual total liabilities of UMediC Group Berhad from 2020 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-07-31 | RM9.87 Million ≈ $2.48 Million |
-0.70% |
| 2024-07-31 | RM9.93 Million ≈ $2.49 Million |
+1.21% |
| 2023-07-31 | RM9.82 Million ≈ $2.46 Million |
-39.46% |
| 2022-07-31 | RM16.21 Million ≈ $4.07 Million |
-52.58% |
| 2021-07-31 | RM34.19 Million ≈ $8.58 Million |
+47.06% |
| 2020-07-31 | RM23.25 Million ≈ $5.84 Million |
-- |
About UMediC Group Berhad
UMediC Group Berhad, an investment holding company, develops, manufactures, markets, and distributes medical devices and consumables in Malaysia, the Asia Pacific, the Americas, Europe, the Middle East, Africa, and Oceania. The company operates nursing homes and healthcare centers, and other related services; markets and distributes laboratory equipment and consumables; and provides after-sales s… Read more